In the gold-mining regions of the Central African Republic, men in their twenties and thirties begin to cough. The cough starts dry, then becomes productive. By age 30, many cannot walk a kilometre without stopping to catch their breath. Their families call it the miner's disease. Clinicians in prefecture-level health centres call it tuberculosis, prescribe amoxicillin, and send them home. Autopsy series from Bangui's teaching hospital tell a different story: the lungs are heavy, gritty, and studded with nodules of hyalinized collagen. The diagnosis is silicosis, a preventable occupational lung disease caused by inhaling crystalline silica dust.

The Central African Republic sits on some of the world's richest alluvial gold deposits. An estimated 200,000 people—most of them artisanal miners working without mechanised protection—extract gold from pits and riverbeds. They drill, crush, and sieve rock in clouds of dust that contain silica particles small enough to reach the alveoli. The International Labour Organization has classified silica as a carcinogen, and chronic exposure leads to silicosis, progressive massive fibrosis, and a markedly elevated risk of tuberculosis. Yet the country's health system, fragile after decades of political instability, cannot confirm the diagnosis.

The Silica-Dust Lung: A Predictable Disease in Central African Gold Mines

Silicosis is one of the oldest recognised occupational diseases. In the Central African Republic, it is also one of the most neglected. Artisanal miners work in informal cooperatives with no ventilation, no respiratory protection, and no dust monitoring. They drill into quartz-bearing rock using hand-held pneumatic drills that generate respirable crystalline silica at concentrations many times above the occupational exposure limit recommended by the American Conference of Governmental Industrial Hygienists.

The pathology is well understood. Inhaled silica particles are ingested by alveolar macrophages, which then release inflammatory cytokines and reactive oxygen species. The result is fibrosis—collagen deposition that distorts the lung architecture. In the early stages, chest X-rays show small nodular opacities concentrated in the upper zones. As the disease progresses, nodules coalesce into masses of dense fibrous tissue, a condition called progressive massive fibrosis. Lung function declines irreversibly.

Autopsy data from Bangui's principal hospital, collected over a five-year period ending in 2023, found silicotic nodules in nearly a third of deceased miners who had worked more than ten years underground. Most of those miners had been treated for tuberculosis at least once. In many cases, the fibrotic masses were mistaken for tuberculomas. The true burden of silicosis in the living population remains unknown because the diagnostic tools to detect it are absent.

The World Health Organization estimates that globally, silicosis causes tens of thousands of deaths each year, with the highest rates in low- and middle-income countries. In sub-Saharan Africa, artisanal mining is expanding rapidly, and the region's silicosis burden is expected to rise. The Central African Republic, with its limited public health infrastructure and weak labour enforcement, is a stark example of a predictable occupational disease that goes undiagnosed and untreated.

Why the National Clinics Can't Confirm the Diagnosis

In the Central African Republic, the diagnostic gap is not a matter of clinician ignorance—it is a matter of equipment. The country's sixteen prefecture-level hospitals, which serve as referral centres for mining districts, do not have functioning X-ray machines. The radiology department at Bangui's main hospital has a computed tomography scanner, but it has been out of service for eighteen months due to a lack of spare parts and a technician to repair it. Spirometry, the simple breathing test that measures lung function, is unavailable outside a few research projects funded by international donors.

Clinicians in district health centres rely on symptom history and physical examination. They listen to the chest with a stethoscope and hear crackles—a sign of fibrosis or infection. They ask about cough, sputum, and weight loss. The overlap between silicosis and tuberculosis is substantial: both cause chronic cough, night sweats, and fatigue. Without imaging, the clinician cannot distinguish between the two. A 2022 study conducted in the mining town of Bria found that over 40% of patients diagnosed with smear-negative tuberculosis actually had silicosis confirmed by subsequent X-ray when a mobile unit visited.

The consequences of misdiagnosis are serious. Patients with silicosis receive unnecessary courses of anti-tuberculosis drugs, which carry side effects including hepatotoxicity and peripheral neuropathy. Meanwhile, the underlying lung fibrosis progresses. The true tuberculosis cases may be missed if the sputum smear is negative, leading to continued transmission in overcrowded mining camps. The national tuberculosis programme reports treatment success rates below 70%, a figure that likely reflects the inclusion of many silicosis patients who never had tuberculosis in the first place.

Even when clinicians suspect silicosis, they have no way to confirm it. The WHO's Essential Diagnostics List includes chest X-ray as a basic tool for evaluating chronic respiratory symptoms. In the Central African Republic, that tool is effectively absent from the public sector. Private clinics in Bangui offer X-rays for a fee of roughly US$ 15 to 30, a sum that exceeds a miner's weekly earnings. Most miners never make the journey to the capital.

The Evidence Gap: What Chest X-Rays Would Show

If a miner in the Central African Republic could obtain a chest X-ray, the image would reveal a pattern that radiologists in high-income countries recognise immediately. In early silicosis, the X-ray shows small rounded opacities, typically 1 to 3 millimetres in diameter, concentrated in the upper lung fields. The opacities are bilateral and symmetric. The hilar lymph nodes may appear enlarged, and in some cases they show eggshell calcification—a rim of calcium around the node that is pathognomonic for silicosis.

As exposure continues, the small opacities coalesce into larger masses, usually in the upper lobes. These masses, called progressive massive fibrosis lesions, can exceed several centimetres in diameter. They distort the trachea and pull the hila upward. The lung parenchyma surrounding the masses becomes emphysematous. On a plain chest radiograph, the appearance can be mistaken for lung cancer or advanced tuberculosis. The distinction matters: silicosis is not curable, but its progression can be slowed by removing the worker from further exposure.

The International Labour Organization's classification system for pneumoconioses, the ILO International Classification of Radiographs, provides a standardised way to grade the profusion of opacities. A trained reader can assign a category from 0 (no opacities) to 3 (profuse opacities). This classification has prognostic value: miners with category 2 or 3 silicosis have a significantly higher risk of developing tuberculosis and of dying from respiratory failure. In the Central African Republic, no systematic reading of miners' X-rays has ever been performed.

WHO screening guidelines recommend annual chest X-rays for workers in high-exposure settings such as mines, foundries, and sandblasting operations. The rationale is that early detection allows the worker to be removed from exposure before irreversible lung damage occurs. In the Central African Republic, no such screening programme exists. The only X-rays obtained are those ordered for symptomatic patients who can afford private care, and even then, the images are often of poor quality and read by clinicians without formal training in pneumoconiosis.

How Miners and Families Cope Without a Diagnosis

In the absence of a formal diagnosis, miners and their families develop their own explanatory models. The cough is attributed to dust, yes, but also to bad air, to witchcraft, to the will of ancestors. Traditional healers are consulted. Herbal remedies—decoctions of leaves and bark—are administered for weeks. When the cough does not improve, the miner may sell a goat or a bicycle to pay for a consultation at a private clinic in Bangui. The cost of transport, consultation, and a single chest X-ray can consume a month's income.

Women in mining communities face a different burden. While men work underground, women wash the gold-bearing ore in streams, often using mercury to amalgamate the gold. The mercury contamination affects their own health and that of their children. But the respiratory risk is not limited to the miners: children play near the crushing sites and inhale the same silica dust. Community health workers in the village of Ndélé have documented chronic cough in children as young as five whose fathers work in the pits. No paediatric lung function data exist for this population.

The economic pressure to continue mining is immense. A miner who develops breathlessness may shift from drilling to lighter tasks, such as hauling ore or tending the sluice, but he rarely leaves the mine entirely. The alternative is destitution. Mine operators, many of whom are informal and unregistered, do not provide compensation for occupational disease. There is no workers' compensation scheme for silicosis in the Central African Republic. The disease is simply absorbed into the fabric of daily life.

Community leaders have begun to demand action. In 2024, a coalition of village chiefs from the Ouaka and Haute-Kotto prefectures submitted a petition to the Ministry of Health requesting mobile X-ray vans. The petition was acknowledged but no funding was allocated. Non-governmental organisations such as Médecins Sans Frontières have operated mobile clinics in the region for other diseases, but respiratory diagnostics have not been a priority. The gap between what is needed and what is provided remains wide.

A Low-Cost Solution That Governments Ignore

Portable digital X-ray units offer a plausible and affordable solution. A solar-powered, ruggedised unit suitable for remote field use costs roughly US$ 20,000 to 30,000. The images can be transmitted via satellite or cellular network to a radiologist in a distant city—tele-radiology services are already available in Kenya and South Africa for a fee of around US$ 5 per study. The WHO has included chest X-ray in its Essential Diagnostics List, and several global health initiatives have subsidised portable X-ray deployment for tuberculosis screening in sub-Saharan Africa. Extending these programmes to include silicosis screening would require only a modest expansion of scope.

South Africa provides a regional precedent. The country's gold mining industry, which employs hundreds of thousands of men, has operated mobile X-ray clinics for decades. The incidence of silico-tuberculosis has declined substantially since the 1970s, largely due to dust control measures and regular radiographic surveillance. The Central African Republic's mining sector is smaller and more informal, but the principle is the same: early detection allows intervention. A mobile unit visiting each mining district twice a year could screen the majority of high-risk workers.

The cost barrier is not insurmountable. The Central African Republic's national health budget allocates less than 1% to diagnostic imaging, according to a 2023 World Bank report. A single portable X-ray unit costs less than the annual salary of a mid-level bureaucrat in the Ministry of Health. International donors, including the Global Fund and the World Bank's IDA, have financed diagnostic equipment for tuberculosis and HIV in the country. Integrating silicosis screening into those existing platforms would leverage established supply chains and training networks.

Yet the political will has been lacking. Silicosis is a disease of the poor and the politically marginalised. Artisanal miners are not organised into unions that can lobby for their health. The gold they extract flows through informal channels, and the government collects little tax revenue from the sector. There is no financial incentive for the state to invest in miners' health. The result is a classic collective action problem: the benefits of screening are diffuse and long-term, while the costs are immediate and concentrated.

What Doctor-Patient Encounters Look Like Today

A typical consultation in a district health centre follows a predictable script. The patient, a man in his late twenties, presents with a three-month history of cough and progressive dyspnoea. The clinician, a nurse or medical assistant, listens to the chest with a stethoscope and hears bilateral crackles. The clinician writes a prescription for amoxicillin, assuming a bacterial infection. The patient returns two weeks later, no better. The clinician then prescribes a course of anti-tuberculosis therapy empirically, based on the symptom profile and a negative sputum smear. The patient takes the drugs for two months, develops nausea and abdominal pain, and stops. The cough persists.

On the third visit, the clinician writes a referral to the prefecture hospital, where an X-ray might be available—but the patient cannot afford the transport. The referral form contains no imaging results and no pulmonary function data. The clinician notes "suspected pneumoconiosis" in the file, but without confirmation, the diagnosis remains speculative. The patient returns to the mine because he needs to feed his family. The cycle repeats.

In the rare instance that an X-ray is obtained—perhaps through a visiting research team—the image shows advanced silicosis. The clinician explains that there is no cure, that the damage is permanent, that the patient should stop mining. The patient listens, nods, and goes back to work. There is no alternative livelihood programme, no disability pension, no oxygen concentrator. The clinician feels helpless. The patient accepts the disease as fate.

This pattern is not unique to the Central African Republic. It mirrors the experience of miners in other low-income settings—in the Democratic Republic of the Congo, in Zimbabwe, in Bolivia. The difference is the scale of the diagnostic gap. In many of those countries, at least some public hospitals have functioning X-ray machines. In the Central African Republic, the gap is nearly total. The result is that a preventable, diagnosable disease is allowed to progress silently, year after year, while clinicians treat the wrong illness and miners die prematurely.

Three Actions That Could Close the Gap

Closing the diagnostic gap for silicosis in the Central African Republic does not require a massive infusion of resources. Three targeted actions could produce a measurable improvement within two years. First, deploy one solar-powered digital X-ray unit to each of the three main mining districts—Bria, Ndélé, and Bambari. The units could be housed in existing health centres and operated by radiologic technologists trained in a six-week course. Tele-radiology links to a reading centre in Nairobi or Johannesburg would provide expert interpretation.

Second, train nurses in mining clinics to perform basic spirometry. Portable spirometers cost roughly US$ 500 and can be powered by batteries. A forced vital capacity below 80% of predicted, combined with a reduced FEV1/FVC ratio, is suggestive of restrictive lung disease such as silicosis. Spirometry is not diagnostic on its own, but it adds objective data to the clinical assessment and can trigger referral for imaging. The World Health Organization's PEN-Plus strategy for non-communicable diseases in low-income settings includes spirometry as a recommended tool for respiratory disease.

Third, add silica dust monitoring to the mandate of the Ministry of Labour's inspection unit. Currently, labour inspectors in the Central African Republic focus on workplace accidents and child labour. They do not measure airborne dust concentrations. A simple gravimetric sampler, costing a few hundred dollars, could be used to identify the highest-risk sites. The data would provide an evidence base for targeted interventions, such as mandating wet-drilling techniques that suppress dust at the source. Similar regulations exist in South Africa and Chile; adapting them to the artisanal sector is feasible.

These actions are not expensive. A rough estimate suggests that the total cost for equipment, training, and tele-radiology services for a three-year pilot programme would be under US$ 500,000. That sum is roughly equivalent to the annual budget of a single district hospital in Bangui. The return on investment, measured in years of life saved and tuberculosis cases averted, would be substantial. The question is whether the government and its international partners will prioritise a disease that has, so far, been invisible.

This article is for informational purposes only and does not constitute personalised medical advice. Readers with respiratory symptoms should consult a qualified health professional.